AtriCure, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-10.00
-43.00
-29.00
-46.00
50.00
-48.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-4.00
-18.00
-18.00
-18.00
-4.00
-6.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
57.00
11.00
4.00
-22.00
-13.00
-19.00
Cash Flow from Investing Activities
-14.00
30.00
21.00
44.00
23.00
-156.00
Cash Flow from Financing Activities
1.00
-2.00
0.00
-7.00
-7.00
189.00
Net Cash Inflow / Outflow
44.00
38.00
26.00
14.00
1.00
13.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of AtriCure, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-10.163
110.330000000244
-120.00
-109.21%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-4.286
-24.2950000000538
20.00
82.36%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
57.334
85.2570000001882
-28.00
-32.75%
Cash Flow from Investing Activities
-14.55
186.032000000412
-200.00
-107.82%
Cash Flow from Financing Activities
1.176
-126.059000000279
127.00
100.93%
Net Cash Inflow / Outflow
44.707
147.214000000326
-103.00
-69.63%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.747
1.98400000000439
-1.00
-62.35%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 414.90% vs 151.70% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
57.33
11.13
414.90%






